跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,894 条关于
“AtaiBeckley Inc.”
全部
40,894
临床试验
11,201
药物
1,598
机构
6,168
资讯
21,927
上个月
Eli Lilly to Acquire AtaiBeckley for Up to $3.8 Billion in Landmark Psychedelic Medicine Deal
6个月前
AtaiBeckley Explores $2 Billion Deal for Psychedelic Depression Drug as Deutsche Bank Sees Major Market Potential
6个月前
AtaiBeckley Advances BPL-003 to Phase 3 Trials for Treatment-Resistant Depression Following FDA Approval
上个月
Eli Lilly to Acquire Psychedelic Drugmaker AtaiBeckley for $2.8 Billion
6天前
Lilly Closes $2.8B AtaiBeckley Acquisition, Adding Rapid-Acting Neuroplastogen BPL-003 for Treatment-Resistant Depression
9个月前
AtaiBeckley Secures Key U.S. Patent for EMP-01 Psychedelic Therapy, Extending Exclusivity Through 2043
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
去年
IDEAYA Biosciences, Inc. (IDYA) BCG Matrix Analysis 2024
第 1 页,共 2193 页
上一页
下一页